Nanjing Hicin Pharmaceutical Co., Ltd. Announces 2019 Final Distribution Plan to Be Implemented (A Shares), Payable on May 14, 2020
May 07, 2020 at 08:37 pm
Share
Nanjing Hicin Pharmaceutical Co., Ltd. announced 2019 final distribution plan to be implemented (A shares), of CNY 2.5000 per 10 shares. The dividend is payable on may 14, 2020 of the record date May 13, 2020. The ex dividend date is May 14, 2020.
Nanjing Hicin Pharmaceutical Co Ltd is a pharmaceutical company engaged in research, development and production of chemical preparations, active pharmaceutical ingredients and intermediates. The Company's primary products are torsemide for injection, tigecycline for injection, cefoxitin sodium for injection, cefotiam for injection and omeprazole sodium for injection. The torsemide for injection is a loop diuretic. The tigecycline for injection is an intravenous administrated glycyrrhizin antibiotic for the treatment of complex skin and skin structure infections or complex intra-abdominal infections. The cefoxitin sodium for injection is a cephalosporin antibiotic used for the treatment of respiratory, urinary and gastrointestinal infections. Its products cover a range of therapeutic areas, including diuresis, cardiovascular, anti-infection, digestive system, immune regulation, hypoglycemic and orthopedics.
NANJING HICIN PHARMACEUTICAL CO., LTD. 
